The gene therapy improved motor functions in children with Duchenne muscular dystrophy two years after treatment ...
Roche announces positive results from EMBARK phase III study of Elevidys in ambulatory individuals with DMD: Basel Tuesday, January 28, 2025, 11:00 Hrs [IST] Roche announced posit ...
Top-line Phase 3 trial data show ambulatory boys with Duchenne continued with motor improvements two years after a single ...
Qatar Tribune on MSN2h
Sidra establishes Gene Therapy Center for rare genetic diseasesTribune News NetworkDohaSidra Medicine, a member of Qatar Foundation, has established a Gene Therapy Center to treat rare genetic diseases such as Spinal Muscular Atrophy (SMA) and Duchenne Muscular ...
GlobalData on MSN13h
Roche reports positive topline outcomes from DMD treatment trialRoche has reported positive topline outcomes from the second year of the multinational Phase III EMBARK trial of Elevidys for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback